The company has applied for an EU grant to support ArtiMist trial. If they receive this grant of €6 mill it may preclude the need for any more CR. Also ofcourse any upfront deals will also preclude. The management need to plan for any contingency.
All is factual information and I remain very confident.
On the Bright Side, page-32
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $163.0M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 15.8¢ | 15.0¢ | $198.5K | 1.280M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 438029 | 15.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.5¢ | 283200 | 1 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| ALA (ASX) Chart |